136 related articles for article (PubMed ID: 1701507)
1. [Epidemic keratoconjunctivitis: treatment results during an epidemic].
Hutter H
Klin Monbl Augenheilkd; 1990 Sep; 197(3):214-7. PubMed ID: 1701507
[TBL] [Abstract][Full Text] [Related]
2. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis.
Ghanem RC; Vargas JF; Ghanem VC
Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH
Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347
[TBL] [Abstract][Full Text] [Related]
5. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis.
Okumus S; Coskun E; Tatar MG; Kaydu E; Yayuspayi R; Comez A; Erbagci I; Gurler B
BMC Ophthalmol; 2012 Aug; 12():42. PubMed ID: 22900547
[TBL] [Abstract][Full Text] [Related]
7. Delayed trifluridine treatment of subepithelial corneal infiltrates.
Kana JS
Am J Ophthalmol; 1992 Feb; 113(2):212-4. PubMed ID: 1550196
[No Abstract] [Full Text] [Related]
8. Topical Tacrolimus for Corneal Subepithelial Infiltrates Secondary to Adenoviral Keratoconjunctivitis.
Berisa Prado S; Riestra Ayora AC; Lisa Fernández C; Chacón Rodríguez M; Merayo-Lloves J; Alfonso Sánchez JF
Cornea; 2017 Sep; 36(9):1102-1105. PubMed ID: 28704319
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
Jeng BH; Holsclaw DS
Cornea; 2011 Sep; 30(9):958-61. PubMed ID: 21673568
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic Treatment of Subepithelial Infiltrates after Viral Conjunctivitis: Loteprednol or Dexamethasone?
Koçluk Y; Sukgen EA; Cevher S; Mat E
Ocul Immunol Inflamm; 2017 Oct; 25(5):649-653. PubMed ID: 27015587
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.
Asena L; Şıngar Özdemir E; Burcu A; Ercan E; Çolak M; Altınörs DD
Eye (Lond); 2017 May; 31(5):781-787. PubMed ID: 28157224
[TBL] [Abstract][Full Text] [Related]
12. [Personal experience with the use of Betadine gtt. in the treatment of epidemic viral keratoconjunctivitis].
Pernický J
Cesk Oftalmol; 1994 Oct; 50(5):323-4. PubMed ID: 7805123
[No Abstract] [Full Text] [Related]
13. Correlation between corneal involvement and anterior chamber flare in epidemic keratoconjunctivitis.
Kiyat P; Palamar M; Yilmaz SG; Emre S
Eur J Ophthalmol; 2020 Sep; 30(5):897-900. PubMed ID: 31111724
[TBL] [Abstract][Full Text] [Related]
14. A prospective, masked clinical trial of trifluridine, dexamethasone, and artificial tears in the treatment of epidemic keratoconjunctivitis.
Ward JB; Siojo LG; Waller SG
Cornea; 1993 May; 12(3):216-21. PubMed ID: 8500334
[TBL] [Abstract][Full Text] [Related]
15. Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
Levinger E; Slomovic A; Sansanayudh W; Bahar I; Slomovic AR
Cornea; 2010 Jun; 29(6):638-40. PubMed ID: 20458220
[TBL] [Abstract][Full Text] [Related]
16. The Treatment Models for Adenoviral Keratoconjunctivitis in the Childhood Population.
Bekmez S; Eris E
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1627-1632. PubMed ID: 32643975
[No Abstract] [Full Text] [Related]
17. Use of human fibroblast-derived (beta) interferon in the treatment of epidemic adenovirus keratoconjunctivitis.
Romano A; Revel M; Guarari-Rotman D; Blumenthal M; Stein R
J Interferon Res; 1980; 1(1):95-100. PubMed ID: 6180050
[TBL] [Abstract][Full Text] [Related]
18. [Express diagnosis of eye adenovirus infection by fluorescent antibody method].
Kasparova EA; Marchenko NR; Loseva IE
Vestn Oftalmol; 1998; 114(4):24-6. PubMed ID: 9771083
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis.
Bhargava R; Kumar P
Indian J Ophthalmol; 2019 May; 67(5):594-598. PubMed ID: 31007215
[TBL] [Abstract][Full Text] [Related]
20. Use of vidarabine in epidemic keratoconjunctivitis due to adenovirus types 3, 7, 8, and 19.
Waring GO Ed; Laibson PR; Satz JE; Joseph NH
Am J Ophthalmol; 1976 Nov; 82(5):781-5. PubMed ID: 187059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
